"I'm Clean and Sober, but Not Necessarily Free": Perceptions of Buprenorphine Among Patients in Long-Term Treatment

Authors

Jessica J. Wyse, OHSU-PSU School of Public HealthFollow
Travis I. Lovejoy, Oregon Health & Science University
Adam J. Gordon, University of Utah
Katherine Mackey, Oregon Health & Science University
Anders Herreid-O'Neill, Oregon Health & Science University
Benjamin J. Morasco, Oregon Health & Science University

Published In

Substance Abuse

Document Type

Article

Publication Date

5-3-2023

Abstract

Patients receiving buprenorphine for the treatment of opioid use disorder (OUD) experience a roughly 50% reduction in mortality risk relative to those not receiving medication. Longer periods of treatment are also associated with improved clinical outcomes. Despite this, patients often express desires to discontinue treatment and some view taper as treatment success. Little is known about the beliefs and medication perspectives of patients engaged in long-term buprenorphine treatment that may underlie motivations to discontinue.

Rights

© 2023 by The Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA), Inc.

Locate the Document

https://doi.org/10.1177/08897077231165625

DOI

10.1177/08897077231165625

Persistent Identifier

https://archives.pdx.edu/ds/psu/40568

Citation Details

Wyse, J. J., Lovejoy, T. I., Gordon, A. J., Mackey, K., Herreid-O’Neill, A., & Morasco, B. J. (2023). “I’m Clean and Sober, But Not Necessarily Free”: Perceptions of Buprenorphine Among Patients in Long-Term Treatment. Substance Abuse, 44(1), 41–50.